Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these numbers and just throw up their hands in fear or resignation.

Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.

Prostate cancer is one of the most common types of cancer that affects men. Understanding what it is, who is at risk and how ...

"It is very reassuring," said study author Recinda Sherman, PhD, MPH, of the North American Association of Central Cancer Registries. "So far, we haven't seen an excess of late-stage diagnoses," which ...

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

Bayer will present new data from the ARANOTE trial evaluating ultra-low prostate-specific antigen responses with NUBEQA ® ...

An at-home spit test is better at identifying prostate cancer risks in some men than the standard test on the market, a new study has found. The findings mean those at higher risk of prostate ...

is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results of the BARCODE 1 study, which have been published in ...

A new spit test for prostate cancer which can be done at home may ... as it reduced the number of false positive results and detected a higher proportion of aggressive cancers than the PSA test.

A new at-home saliva test ... prostate cancer or an enlarged prostate. The new saliva test could be used as an additional screening tool, experts said, as it reduced the number of false positive ...